Literature DB >> 35437318

Social motivation a relative strength in DYRK1A syndrome on a background of significant speech and language impairments.

Lottie D Morison1, Ruth O Braden1, David J Amor1,2,3, Amanda Brignell1,4,5, Bregje W M van Bon6, Angela T Morgan7,8,9.   

Abstract

Speech and language impairments are commonly reported in DYRK1A syndrome. Yet, speech and language abilities have not been systematically examined in a prospective cohort study. Speech, language, social behaviour, feeding, and non-verbal communication skills were assessed using standardised tools. The broader health and medical phenotype was documented using caregiver questionnaires, interviews and confirmation with medical records. 38 individuals with DYRK1A syndrome (23 male, median age 8 years 3 months, range 1 year 7 months to 25 years) were recruited. Moderate to severe intellectual disability (ID), autism spectrum disorder (ASD), vision, motor and feeding impairments were common, alongside epilepsy in a third of cases. Speech and language was disordered in all participants. Many acquired some degree of verbal communication, yet few (8/38) developed sufficient oral language skills to rely solely on verbal communication. Speech was characterised by severe apraxia and dysarthria in verbal participants, resulting in markedly poor intelligibility. Those with limited verbal language (30/38) used a combination of sign and graphic augmentative and alternative communication (AAC) systems. Language skills were low across expressive, receptive, and written domains. Most had impaired social behaviours (25/29). Restricted and repetitive interests were most impaired, whilst social motivation was a relative strength. Few individuals with DYRK1A syndrome use verbal speech as their sole means of communication, and hence, all individuals need early access to tailored, graphic AAC systems to support their communication. For those who develop verbal speech, targeted therapy for apraxia and dysarthria should be considered to improve intelligibility and, consequently, communication autonomy.
© 2022. The Author(s), under exclusive licence to European Society of Human Genetics.

Entities:  

Mesh:

Year:  2022        PMID: 35437318      PMCID: PMC9259653          DOI: 10.1038/s41431-022-01079-w

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   5.351


  27 in total

1.  Clinical assessment of oropharyngeal motor development in young children.

Authors:  J Robbins; T Klee
Journal:  J Speech Hear Disord       Date:  1987-08

2.  DYRK1A: a master regulatory protein controlling brain growth.

Authors:  Fayçal Guedj; Patricia Lopes Pereira; Sonia Najas; Maria-Jose Barallobre; Caroline Chabert; Benoit Souchet; Catherine Sebrie; Catherine Verney; Yann Herault; Mariona Arbones; Jean M Delabar
Journal:  Neurobiol Dis       Date:  2012-01-26       Impact factor: 5.996

3.  Deep phenotyping of speech and language skills in individuals with 16p11.2 deletion.

Authors:  Cristina Mei; Evelina Fedorenko; David J Amor; Amber Boys; Caitlyn Hoeflin; Peter Carew; Trent Burgess; Simon E Fisher; Angela T Morgan
Journal:  Eur J Hum Genet       Date:  2018-02-14       Impact factor: 4.246

Review 4.  Interventions for oropharyngeal dysphagia in children with neurological impairment.

Authors:  Angela T Morgan; Pamela Dodrill; Elizabeth C Ward
Journal:  Cochrane Database Syst Rev       Date:  2012-10-17

5.  Impaired development of neocortical circuits contributes to the neurological alterations in DYRK1A haploinsufficiency syndrome.

Authors:  Juan Arranz; Elisa Balducci; Krisztina Arató; Gentzane Sánchez-Elexpuru; Sònia Najas; Alberto Parras; Elena Rebollo; Isabel Pijuan; Ionas Erb; Gaetano Verde; Ignasi Sahun; Maria J Barallobre; José J Lucas; Marina P Sánchez; Susana de la Luna; Maria L Arbonés
Journal:  Neurobiol Dis       Date:  2019-03-01       Impact factor: 5.996

6.  Disruptive de novo mutations of DYRK1A lead to a syndromic form of autism and ID.

Authors:  B W M van Bon; B P Coe; R Bernier; C Green; J Gerdts; K Witherspoon; T Kleefstra; M H Willemsen; R Kumar; P Bosco; M Fichera; D Li; D Amaral; F Cristofoli; H Peeters; E Haan; C Romano; H C Mefford; I Scheffer; J Gecz; B B A de Vries; E E Eichler
Journal:  Mol Psychiatry       Date:  2015-02-24       Impact factor: 15.992

Review 7.  Interventions for childhood apraxia of speech.

Authors:  Angela T Morgan; Elizabeth Murray; Frederique J Liégeois
Journal:  Cochrane Database Syst Rev       Date:  2018-05-30

8.  Clinical phenotype of ASD-associated DYRK1A haploinsufficiency.

Authors:  Rachel K Earl; Tychele N Turner; Heather C Mefford; Caitlin M Hudac; Jennifer Gerdts; Evan E Eichler; Raphael A Bernier
Journal:  Mol Autism       Date:  2017-10-05       Impact factor: 7.509

9.  Severe speech impairment is a distinguishing feature of FOXP1-related disorder.

Authors:  Ruth O Braden; David J Amor; Simon E Fisher; Cristina Mei; Candace T Myers; Heather Mefford; Deepak Gill; Siddharth Srivastava; Lindsay C Swanson; Himanshu Goel; Ingrid E Scheffer; Angela T Morgan
Journal:  Dev Med Child Neurol       Date:  2021-06-09       Impact factor: 5.449

Review 10.  DYRK1A pathogenic variants in two patients with syndromic intellectual disability and a review of the literature.

Authors:  Laura E Meissner; Ellen F Macnamara; Precilla D'Souza; John Yang; Gilbert Vezina; Carlos R Ferreira; Wadih M Zein; Cynthia J Tifft; David R Adams
Journal:  Mol Genet Genomic Med       Date:  2020-11-07       Impact factor: 2.183

View more
  1 in total

1.  Clinical genomics testing: mainstreaming and globalising.

Authors:  Alisdair McNeill
Journal:  Eur J Hum Genet       Date:  2022-07       Impact factor: 5.351

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.